| Secondary |
| Hypertension |
16.9% |
| Immunisation |
10.8% |
| Gastritis |
9.6% |
| Prophylaxis |
9.6% |
| Hepatitis C |
6.0% |
| Hiv Infection |
6.0% |
| Multiple Sclerosis |
6.0% |
| Anaemia |
4.8% |
| Lipid Metabolism Disorder |
4.8% |
| Drug Use For Unknown Indication |
3.6% |
| Antidepressant Therapy |
2.4% |
| Contraception |
2.4% |
| Gastrointestinal Disorder |
2.4% |
| Gastrointestinal Disorder Therapy |
2.4% |
| Insomnia |
2.4% |
| Paroxysmal Nocturnal Haemoglobinuria |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Asthma |
1.2% |
| Bladder Cancer |
1.2% |
|
| Pneumonia |
8.3% |
| Prurigo |
8.3% |
| Vaccination Site Cellulitis |
8.3% |
| Visual Impairment |
8.3% |
| Arthritis Bacterial |
4.2% |
| Cellulitis |
4.2% |
| Drug Hypersensitivity |
4.2% |
| Erythema |
4.2% |
| Foetal Exposure During Pregnancy |
4.2% |
| Gastrointestinal Obstruction |
4.2% |
| Haemoglobin Decreased |
4.2% |
| Hypersensitivity |
4.2% |
| Increased Upper Airway Secretion |
4.2% |
| Movement Disorder |
4.2% |
| Nasopharyngitis |
4.2% |
| Paraesthesia |
4.2% |
| Rash Maculo-papular |
4.2% |
| Suicide Attempt |
4.2% |
| Swelling |
4.2% |
| Therapeutic Response Decreased |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.8% |
| Multiple Myeloma |
15.9% |
| Drug Use For Unknown Indication |
13.5% |
| Pain |
10.5% |
| Rheumatoid Arthritis |
5.5% |
| Restless Legs Syndrome |
4.3% |
| Hypertension |
4.2% |
| Breast Cancer |
3.1% |
| Nausea |
3.1% |
| Osteoporosis |
2.9% |
| Constipation |
2.5% |
| Dyspepsia |
1.9% |
| Glaucoma |
1.8% |
| Hypotension |
1.8% |
| Prophylaxis |
1.8% |
| Anxiety |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Insomnia |
1.7% |
| Multiple Sclerosis |
1.7% |
| Blood Cholesterol Increased |
1.6% |
|
| Weight Decreased |
17.5% |
| Vomiting |
11.1% |
| Vision Blurred |
9.5% |
| Thrombocytopenia |
7.1% |
| Tooth Extraction |
6.3% |
| Weight Increased |
6.3% |
| Pyrexia |
5.6% |
| Pneumonia |
4.0% |
| Tachycardia |
4.0% |
| Cellulitis |
3.2% |
| Febrile Neutropenia |
3.2% |
| Myocardial Infarction |
3.2% |
| Dizziness |
2.4% |
| Drug Exposure During Pregnancy |
2.4% |
| Dyspepsia |
2.4% |
| Dyspnoea |
2.4% |
| Haemoglobin Decreased |
2.4% |
| Hyperlipidaemia |
2.4% |
| Urinary Tract Infection |
2.4% |
| White Blood Cell Count Increased |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Psoriasis |
50.0% |
|
|
